AIM Breakfasts

AIM BREAKFAST – 1st September 2016

Set Menu AIM:

Total number of AIM Companies (Incl Susp): 1,006

Total number of AIM Companies trading: 993*
* As at 30 August 2016

Dish of the Day:

No primary today.

Off the Menu:

No AIM Leavers today

Set Menu ISDX Growth:

Total number of ISDX Growth Market Companies (Incl Susp): *

Total number of ISDX Growth Market Companies trading: *
* As at 30 August 2016

Dish of the Day:

Off the Menu:

What’s Cooking in the IPO Kitchen?

Misys— The press reports that the Banking Technology provider owned by Vista Equity Partners is seeking a £5.5bn float in London

Bacanora Lithium— To list on AIM around 28 Sep as holding company for TSX listed Bacanora Minerals at £100m market cap

Aura Energy—ASX listed uranium developer (ASX:AEE) expected to join AIM 6 September

Breakfast Buffet

Metal Tiger (MTR.L) 3.53p £20.2m

The investor in strategic natural resource projects announced a strategic investment totalling £100,000 in Thor Mining (THR.L).  At 0.025p including one for one warrants. Paul Johnson, Chief Executive Officer of Metal Tiger to join the board of Thor Mining as a non-executive director. A drilling campaign has recently commenced at Thor’s Molyhill Tungsten project  in Australia’s Northern Territory where there is an existing 13,100 tonne of contained WO3 reserve plus other metals.

Stilo International (STL.L) 8p £8.99m

The provider of XML cloud content conversion, content processing and authoring tools, today announced its H1 Jun 16 Interim Results. Sales revenues for six months to 30 June 2016 increase by 11% to £874,000.  Increase in EBITDA by 11% to £184,000. Cash position increased by 30% to £1,393,000. Interim dividend up by a third to 0.04p. Trading in 2016 continues in line with management expectations. Stilo continues to invest in the development of innovative new products to underpin future growth. There are no forecasts in the market.

Jaywing (JWNG.L) 30p £22.9m

The UK-based agency specialising in the application of data science is acquiring Leeds based digital marketing agency Bloom Media for an initial £2.4m with an earn out of up to £5.75m. The Acquisition is expected to be earnings enhancing within 12 months from completion. The company has raised £3m  in a placing at 30p. For FYFeb16, Bloom generated gross profit and profit before tax of £1,943,000 and £279,000 respectively. FYMar17E forecasts for Jaywing suggest revenue o £37.7m and EPS of 3.8p.

Water Intelligence (WATR.L) 86p £9.1m

The provider of non-invasive leak detection and remediation solutions,  has acquired NRW Utilities for £575k. NRW brings several synergies to the growth of Water Intelligence’s core American Leak Detection business and reinforces the Company’s Anglo-American partnership. NRW generated revenues of £672k and was breakeven for its first fiscal year ended 29 February 2016. Water Intelligence turned over $8.8m in 2015 with $0.97m PBT. There are no forecasts in the market.

New World Oil & Gas (NEW.L) Suspended

The company has updated on the possible reverse takeover of video analytics company Big Sofa. The Company is continuing to make good progress with the possible reverse takeover of Big Sofa and the Board remains of the view that this acquisition is an attractive proposition for New World shareholders.  Big Sofa is continuing to win new mandates and New World has made a further £100k loan.   The company is seeking to dispose or relinquish its remaining oil and gas asset.

Sirius Minerals (SXX.L) 41.25p £951.8m

Sirius has updated on the financing for its North Yorkshire polyhalite project. Following a market sounding with debt lenders the Company has now mandated a group of six financial institutions experienced in mining and infrastructure project finance as Mandated Lead Arrangers. Once approved the Stage 2 financing is expected to comprise aggregate senior debt facilities of up to US$2.6bn to fund the Stage 2 capital funding requirement and costs relating to financing the Project.  Financial close for the Facilities is expected to take place in 2018.

Vertu motors (VTU.L) 48.5p £192.68m

The automotive retailer with a network of 132 sales and aftersales outlets across the UK, has issued a pre close update for H1Aug106. Robust trading in H1. Profitability up. The Board expects that the Group’s full year results will be in line with market expectations with record revenues and profits. The macro-economic environment of historically record low interest rates and record high levels of employment in the UK provide a favourable economic backdrop for the sector.  No Brexit impact. 7.8x PE and 2.8% yield.

Paysafe Group (PAYS.L) 436.7p £2.1bn

The global provider of payment solutions, is expanding its product capabilities by acquiring Income Access Group, a pioneering affiliate technology business for a cash consideration of CAD40m.  In the last fiscal year to 31 March 2016 of Income Access, the business generated approximately CAD3.3m of profit before income taxes vs £157.8m forecast for the Group in FYDec2016.  The shares are on 15x earnings.

Tissue Regenix Group (TRX.L) 20p £152m.

The regenerative medical devices company has gained Medicare coverage in an additional 10 States covered by Medicare jurisdiction National Government Services (NGS) for the use of DermaPure®. This new coverage adds an additional 7.5 million Medicare beneficiaries and means that Tissue Regenix has now secured Medicare reimbursement in 47 States, totalling 93% of traditional Medicare beneficiaries. Consensus forecasts FY Jan2017 revenue of £3.55m and an £11.7m loss.

ProPhotonix (PPIX.L) 2.88p £2.4m

The high technology designer and manufacturer of LED illumination systems and laser diode modules, is pleased to announce that it will be exhibiting its range of UV LED Curing systems at Label Expo Americas, 13th – 15th September, Booth 3620. In recent months, ProPhotonix has launched the COBRA Cure FX Series of innovative UV LED Curing Systems, designed specifically for UV curing of inks, coatings and adhesives.

Head Chef:

Derren Nathan
0203 764 2344

*A corporate client of Hybridan LLP


This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX. If you would like to unsubscribe, please email with “unsubscribe me”.